期刊文献+

心房颤动导管消融的地位和进展 被引量:1

The status and advances of radiofrequency catheter ablation for atrial fibrillation
下载PDF
导出
摘要 心房颤动(房颤)是临床常见的心律失常之一,最大风险是血栓栓塞,常见是脑卒中。随着人口的老龄化,房颤人数持续增加,治疗问题也逐渐成为人们关注重点。房颤导管消融是其重要治疗方法之一,可明显改善房颤患者预后。且随着技术发展,消融方法也日趋成熟,故导管消融术治疗房颤地位正在逐步提升。但消融方法尚无固定术式,发生机制尚未完全明确,尤其对于持续房颤。因此房颤消融术仍存在一些问题有待进一步探索。 Atrial fibrillation is one of the most common arrhythmias in clinic.The biggest risk of atrial fibrillation is thromboembolism,the most common complication is stroke.With the aging of population,more and more people suffer from atrial fibrillation,so the treatment of atrial fibrillation has gradually become the focus problem.Radiofrequency catheter ablation for atrial fibrillation is one of the important treatment methods,it can obviously improve the prognosis of patients with atrial fibrillation.And with the development of technology,ablation method has been mature,the status of radiofrequency catheter ablation for atrial fibrillation is gradually improved.However,there is no fixed operation method up to now.The mechanism of atrial fibrillation is not thoroughly explicit,especially for persistent atrial fibrillation.There are still some problems with radiofrequency catheter ablation for atrial fibrillation to further investigate.
出处 《临床荟萃》 CAS 2016年第1期19-21,26,共4页 Clinical Focus
关键词 心房颤动 导管消融术 atrial fibrillation radiofrequency catheter ablation
  • 相关文献

参考文献13

  • 1Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins[J]. N Engl J Med,1998,339(10): 659-666.
  • 2Saad EB, Rossillo A, Saad CP, et al. Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy[J]. Circulation,2003,108(25) : 3102-3107.
  • 3Pappone C, Manguso F, Vieedomini G, et al. Prevention of iatrogenic atrial tachycardia after ablation of atrial fibrillation: a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach [J].Circulation, 2004,110(19) : 3036-3042.
  • 4Dong JZ, Sang CH, Yu RH, et al. Prospective randomized comparison between a fixed '2C3L" approach vs. stepwise approach for catheter ablation of persistent atrial fibrillation [J]. Europace,2015,May 8.[Epub ahead of print].
  • 5Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation[J]. Circulation, 2005,111 (9): 1100- 1105.
  • 6Ren JF, Marchlinski FE, Callans DJ, et al. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast[J]. J Cardiovase Electrophysiol, 2005,16(5) :474-477.
  • 7Pappone C, Rosanio S, Augello G, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation {or atrial fibrillation: outcomes from a controlled nonrandomized long-term study[J]. J Am Coil Cardiol,2003, 42(2) : 185-197.
  • 8Morillo CA, Verma A, Connolly SJ, et al. Radiofrequency ablation vs antiarrhythmie drugs as first line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial [J]. JAMA,2014,311(7): 692-700.
  • 9Raatikainen MJ, Hakalahti A, Uusimaa P, et al. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmie medication in patients with paroxysmal atrial fibrillation.. On-treatment analysis of the randomized controlled MANTRA-PAF trial[J]. Int J Cardiol,2015,198: 108-114.
  • 10Oral H, Pappone C, Chugh A, et al. Circumferential pulmonary vein ablation for chronic atrial fibrillation [J]. N Engl J Med,2006,354(9) : 934-941.

二级参考文献26

  • 1唐其柱,黄峥嵘,史锡腾,王腾,沈涤非.甘松提取物对单个兔心室肌细胞钠、钙通道的影响[J].中国心脏起搏与心电生理杂志,2004(z1). 被引量:115
  • 2胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 3晋军,黄岚,张殿新.稳心颗粒对房颤患者心房肌细胞膜钾、钙离子通道改变的影响[J].中医杂志,2007,48(2):122-122. 被引量:21
  • 4ACTIVE Writing Group of the ACTIVE investigators,Connolly S,Pogue J,et al. Clopidogrel plus aspirin versus oral antieoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular E- vents ( ACTIVE W ) : a randomized controlled trial [ J ]. Lancet,2006,367 : 1903 - 1912.
  • 5Wasmer K, Eckardt L. Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines [ J ]. Eu- ropace, 2011,13 (10) : 1368-1374.
  • 6Ostermayer S, Reschke M, Bininger K, et al. Percutaneous closure of the left atri- al appendage[J]. J Interv Cardiol,2003,16(6) :553-556.
  • 7Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atria/fibrillation[ J]. N Engl J Med,2009,361:1139-1151.
  • 8ACTIVE Investigators, Connolly SJ, Pogue J, et al. Effect of elopidogrel added to aspirin in patients with atrial fibrillation[J]. N Engl J Med, 2009,360(20) : 2066-2078.
  • 9Meyer D. Antiplatelets and stroke outcomes: state of the science[ J]. Crit Care Nuts Clin Noah Am, 2009, 21 (4) :517-528.
  • 10Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrilIation : re- port from the Stockholm Cohort of Atrial Fibrillation [ J ]. Thromb Haemost, 2009,101:367-372.

共引文献11

同被引文献30

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部